Header Logo

Connection

Philip Bonomi to Proto-Oncogene Proteins c-bcl-2

This is a "connection" page, showing publications Philip Bonomi has written about Proto-Oncogene Proteins c-bcl-2.
  1. Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer. Clin Cancer Res. 2012 Jun 01; 18(11):3163-9.
    View in: PubMed
    Score: 0.107
  2. Apoptosis. J Thorac Oncol. 2009 Nov; 4(11 Suppl 3):S1061-2.
    View in: PubMed
    Score: 0.090
  3. Potential applications of apoptosis in modifying the biological behavior of therapeutically refractory cancers. Med Hypotheses. 1994 Oct; 43(4):207-13.
    View in: PubMed
    Score: 0.032
  4. Altered oncogene, tumor suppressor and cell-cycle gene expression in PANC-1 cells cultured with the pleiotrophic 5-lipoxygenase inhibitor, MK886, assessed with a gene chip. Anticancer Res. 1999 Sep-Oct; 19(5B):3873-87.
    View in: PubMed
    Score: 0.011
  5. Does maximizing programmed cell death necessarily yield an optimum clinical advantage? Med Hypotheses. 1999 Mar; 52(3):235-8.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.